Síntese e caracterização de BioMOFs (Biocompatible Metal-Organic Frameworks) de Zn(II) para aplicação em drug delivery de metalofármacos anticancerígenos

Detalhes bibliográficos
Autor(a) principal: Armando, Renan Augusto Marson
Data de Publicação: 2022
Tipo de documento: Trabalho de conclusão de curso
Idioma: por
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://hdl.handle.net/11449/216625
Resumo: One of the greatest bottlenecks in modern medicine has been the development and use of biocompatible carriers that assure efficient drug delivery in the body. Most of the existing carriers have shown some drawbacks like poor loading and rapid drug release with a "burst" effect. In this context, a subclass of coordination polymers, known as Metal-Organic Frameworks (MOFs), has drawn the attention of researchers across the world: the unique physical properties of MOFs make them exceptional materials for drug delivery systems (DDS). Here, we have synthesized and characterized a non-toxic Zn-based MOF, designated bio-MOF-1, by using 4,4'-biphenyldicarboxylic acid and adenine as linkers. The microcrystalline porous material presented great loading capacity (0.340 g g -1) for the antitumoral metallodrug Ru-90 [cis-[Ru(bpy)2(NO2)(solv)](PF6)]. The release of Ru-90 from the bio-MOF-1 matrix is depending on pH, and therefore, this material is a promising candidate for anticancer drug delivery. The fitting of kinetic equation models showed that the mechanism of Ru-90 release from bio- MOF-1 is adjusted by the Korsmeyer-Peppas model for the system at pH 5,0 and pH 7,4; the plots displayed high linearity and correlation coefficient values (R2 ) greater than 0.96. The n values were under 0.45 (Korsmeyer-Peppas model), which suggested the quasi Fickian model for the transport mechanism. In fact, the kinetic study results showed that bio-MOF-1 delivers the anticancer complex Ru-90 mostly through a diffusive mechanism. The in vitro cytotoxicity results demonstrated that Ru-90 occlusion facilitated its access and increased its availability in the cells A395 (tumoral) and L929 (non-tumoral). Moreover, microcrystalline particles of bio-MOF-1, here named Zn_HAc, Zn_pyd and Zn_pydmicro, were obtained by microwaves-assisted techniques and the addition of coordination modulators. The use of acetic acid as a modulator decreased slightly the size of particles when compared to the conventional solvothermal route. In conclusion, depending on the type of modulator (acetic acid or pyridine) as well as the synthetic route (conventional solvothermal or microwave-assisted), we were capable to obtain different morphologies (rods, spheres, and clusters).
id UNSP_3ebf6e59ffae3f729d1352a0c4cfe03f
oai_identifier_str oai:repositorio.unesp.br:11449/216625
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Síntese e caracterização de BioMOFs (Biocompatible Metal-Organic Frameworks) de Zn(II) para aplicação em drug delivery de metalofármacos anticancerígenosSynthesis and Characterization of Zn-based BioMOFs (Biocompatible Metal-Organic Frameworks) for metallodrug anticancer drug deliveryMOFsSistema de liberação de fármacos (SLF)Fármacos anticancerígenosMetalofármacosOne of the greatest bottlenecks in modern medicine has been the development and use of biocompatible carriers that assure efficient drug delivery in the body. Most of the existing carriers have shown some drawbacks like poor loading and rapid drug release with a "burst" effect. In this context, a subclass of coordination polymers, known as Metal-Organic Frameworks (MOFs), has drawn the attention of researchers across the world: the unique physical properties of MOFs make them exceptional materials for drug delivery systems (DDS). Here, we have synthesized and characterized a non-toxic Zn-based MOF, designated bio-MOF-1, by using 4,4'-biphenyldicarboxylic acid and adenine as linkers. The microcrystalline porous material presented great loading capacity (0.340 g g -1) for the antitumoral metallodrug Ru-90 [cis-[Ru(bpy)2(NO2)(solv)](PF6)]. The release of Ru-90 from the bio-MOF-1 matrix is depending on pH, and therefore, this material is a promising candidate for anticancer drug delivery. The fitting of kinetic equation models showed that the mechanism of Ru-90 release from bio- MOF-1 is adjusted by the Korsmeyer-Peppas model for the system at pH 5,0 and pH 7,4; the plots displayed high linearity and correlation coefficient values (R2 ) greater than 0.96. The n values were under 0.45 (Korsmeyer-Peppas model), which suggested the quasi Fickian model for the transport mechanism. In fact, the kinetic study results showed that bio-MOF-1 delivers the anticancer complex Ru-90 mostly through a diffusive mechanism. The in vitro cytotoxicity results demonstrated that Ru-90 occlusion facilitated its access and increased its availability in the cells A395 (tumoral) and L929 (non-tumoral). Moreover, microcrystalline particles of bio-MOF-1, here named Zn_HAc, Zn_pyd and Zn_pydmicro, were obtained by microwaves-assisted techniques and the addition of coordination modulators. The use of acetic acid as a modulator decreased slightly the size of particles when compared to the conventional solvothermal route. In conclusion, depending on the type of modulator (acetic acid or pyridine) as well as the synthetic route (conventional solvothermal or microwave-assisted), we were capable to obtain different morphologies (rods, spheres, and clusters).Um dos maiores desafios da medicina moderna nas últimas décadas tem sido o desenvolvimento e uso de carreadores biocompatíveis que garantam uma liberação de moléculas bioativas no corpo humano de forma eficiente. A maioria dos carreadores existentes demonstram algumas desvantagens como baixa capacidade de carregamento e rápida liberação com efeito burst. Nesse contexto, uma sub-classe de polímeros de coordenação, conhecida como Metal-Organic Frameworks (MOFs), tem atraído a atenção de pesquisadores do mundo todo posto que as propriedades físicas características das MOFs, principalmente porosidade permanente e elevada área específica, as tornam materiais excepcionais para aplicação em sistemas de liberação de fármacos (SLFs). Neste trabalho, uma MOF não-tóxica à base de íons zinco(II), denominada bio-MOF-1, foi sintetizada e caracterizada utilizando ácido 4,4’-bifenildicarboxílico e adenina como ligantes. O material poroso microcristalino obtido apresentou elevada capacidade de carregamento (0,340 g g-1) do metalofármaco anticancerígeno Ru-90, [cis-[Ru(bpy)2(NO2)(solv)](PF6)]. A liberação do complexo Ru-90 da matriz bio-MOF-1 é dependente do pH, e, portanto, este material se torna um candidato promissor em drug delivery de fármacos anticancerígenos. A aplicação de modelos cinéticos revela que o mecanismo de liberação do Ru-90 dos poros da matriz posora se ajusta à equação de Korsmeyer-Peppas para o sistema em pH 5,0 e pH 7,4; os gráficos mostram elevada linearidade dos dados e coeficiente de correlação (R2) maior que 0,96. O valor de n ficou abaixo de 0,45, sugerindo que o mecanismo de transporte segue um modelo quase-Fickiano. De fato, o estudo cinético sugere que a bio-MOF-1 libera o fármaco principalmente por difusão. Os resultados de viabilidade celular in vitro revelam que a oclusão de Ru-90 facilitou seu acesso e aumentou sua disponibilidade nas células utilizadas: A395 (tumoral) e L929 (não tumoral). Na segunda parte do trabalho, com o objetivo de tentar miniaturizar as partículas da bio-MOF-1, diferentes amostras (Zn_HAc, Zn_pyd, Zn_HAcmicro e Zn_pydmicro) foram obtidas utilizando técnicas de micro-ondas e moduladores de coordenação. A utilização do ácido acético como agente modulador reduziu ligeiramente o tamanho de partícula quando comparado com o método solvotérmico convencional. Foi também observado que, dependendo do tipo de modulador (ácido acético ou piridina) e da rota sintética utilizada (solvotérmica convencional ou assistida por micro-ondas), foi possível também obter compostos com diferentes morfologias (prismas, bastões concêntricos ou partículas quase-esféricas).Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)2017/13961-0Universidade Estadual Paulista (Unesp)Frem, Regina Célia Galvão[UNESP]Universidade Estadual Paulista (Unesp)Armando, Renan Augusto Marson2022-02-16T11:53:46Z2022-02-16T11:53:46Z2022-01-18info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisapplication/pdfhttp://hdl.handle.net/11449/216625porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESP2023-10-15T06:03:00Zoai:repositorio.unesp.br:11449/216625Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T14:56:06.621663Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Síntese e caracterização de BioMOFs (Biocompatible Metal-Organic Frameworks) de Zn(II) para aplicação em drug delivery de metalofármacos anticancerígenos
Synthesis and Characterization of Zn-based BioMOFs (Biocompatible Metal-Organic Frameworks) for metallodrug anticancer drug delivery
title Síntese e caracterização de BioMOFs (Biocompatible Metal-Organic Frameworks) de Zn(II) para aplicação em drug delivery de metalofármacos anticancerígenos
spellingShingle Síntese e caracterização de BioMOFs (Biocompatible Metal-Organic Frameworks) de Zn(II) para aplicação em drug delivery de metalofármacos anticancerígenos
Armando, Renan Augusto Marson
MOFs
Sistema de liberação de fármacos (SLF)
Fármacos anticancerígenos
Metalofármacos
title_short Síntese e caracterização de BioMOFs (Biocompatible Metal-Organic Frameworks) de Zn(II) para aplicação em drug delivery de metalofármacos anticancerígenos
title_full Síntese e caracterização de BioMOFs (Biocompatible Metal-Organic Frameworks) de Zn(II) para aplicação em drug delivery de metalofármacos anticancerígenos
title_fullStr Síntese e caracterização de BioMOFs (Biocompatible Metal-Organic Frameworks) de Zn(II) para aplicação em drug delivery de metalofármacos anticancerígenos
title_full_unstemmed Síntese e caracterização de BioMOFs (Biocompatible Metal-Organic Frameworks) de Zn(II) para aplicação em drug delivery de metalofármacos anticancerígenos
title_sort Síntese e caracterização de BioMOFs (Biocompatible Metal-Organic Frameworks) de Zn(II) para aplicação em drug delivery de metalofármacos anticancerígenos
author Armando, Renan Augusto Marson
author_facet Armando, Renan Augusto Marson
author_role author
dc.contributor.none.fl_str_mv Frem, Regina Célia Galvão[UNESP]
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Armando, Renan Augusto Marson
dc.subject.por.fl_str_mv MOFs
Sistema de liberação de fármacos (SLF)
Fármacos anticancerígenos
Metalofármacos
topic MOFs
Sistema de liberação de fármacos (SLF)
Fármacos anticancerígenos
Metalofármacos
description One of the greatest bottlenecks in modern medicine has been the development and use of biocompatible carriers that assure efficient drug delivery in the body. Most of the existing carriers have shown some drawbacks like poor loading and rapid drug release with a "burst" effect. In this context, a subclass of coordination polymers, known as Metal-Organic Frameworks (MOFs), has drawn the attention of researchers across the world: the unique physical properties of MOFs make them exceptional materials for drug delivery systems (DDS). Here, we have synthesized and characterized a non-toxic Zn-based MOF, designated bio-MOF-1, by using 4,4'-biphenyldicarboxylic acid and adenine as linkers. The microcrystalline porous material presented great loading capacity (0.340 g g -1) for the antitumoral metallodrug Ru-90 [cis-[Ru(bpy)2(NO2)(solv)](PF6)]. The release of Ru-90 from the bio-MOF-1 matrix is depending on pH, and therefore, this material is a promising candidate for anticancer drug delivery. The fitting of kinetic equation models showed that the mechanism of Ru-90 release from bio- MOF-1 is adjusted by the Korsmeyer-Peppas model for the system at pH 5,0 and pH 7,4; the plots displayed high linearity and correlation coefficient values (R2 ) greater than 0.96. The n values were under 0.45 (Korsmeyer-Peppas model), which suggested the quasi Fickian model for the transport mechanism. In fact, the kinetic study results showed that bio-MOF-1 delivers the anticancer complex Ru-90 mostly through a diffusive mechanism. The in vitro cytotoxicity results demonstrated that Ru-90 occlusion facilitated its access and increased its availability in the cells A395 (tumoral) and L929 (non-tumoral). Moreover, microcrystalline particles of bio-MOF-1, here named Zn_HAc, Zn_pyd and Zn_pydmicro, were obtained by microwaves-assisted techniques and the addition of coordination modulators. The use of acetic acid as a modulator decreased slightly the size of particles when compared to the conventional solvothermal route. In conclusion, depending on the type of modulator (acetic acid or pyridine) as well as the synthetic route (conventional solvothermal or microwave-assisted), we were capable to obtain different morphologies (rods, spheres, and clusters).
publishDate 2022
dc.date.none.fl_str_mv 2022-02-16T11:53:46Z
2022-02-16T11:53:46Z
2022-01-18
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/bachelorThesis
format bachelorThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/11449/216625
url http://hdl.handle.net/11449/216625
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128439162503168